New Alzheimer's Drug Shows Promise
An anonymous reader writes "The Herald Sun is reporting that researchers may have some progress to report on the Alzheimer's front. A new drug, called PBT2, was developed by a Melbourne-based biotech firm that has been showing some promising results. From the article: 'Early clinical testing has confirmed the drug is fast-acting. Levels of amyloid dropped by 60 per cent within 24 hours of a single dose. It found also that PBT2 suppresses the impairment of memory function. More human studies begin in Sweden next month and Australians will join a major international trial of the drug next year.'"
I have heard linkages between alzheimers and "mad cow disease", I wonder if this drug will be able to fix both problems. I can finally start eating all cows indiscriminately!!!
You take it, I don't want it...
On the other hand if you take a look at the pdf linked on the homepage (pdf warning), you will see that it is a clinical trial designed to assess both safety and efficacy. It's pretty small numbers though (18 completers) and the efficacy is assesed by cognition tests. There's certainly no mention of amyloid reduction so that may well refer to the animal studies.
Ye have made your way from the worm to man, and much within you is still worm.
Is it just me or does it seem like every few months, the healthcare media pops up an article about some newfangled treatment that shows "promise" for some disease that everyone knows about? And is it me again, or do we almost never hear about these promising treatments years later? The cynic in me would say that it smells like someone trying to drum up some investment money. What's that? Prana Biotechnologies is listed on the Nasdaq as "PRAN"? And the announcement hit the media before the Monday opening bell? I'm shocked.
Sadly, the less cynical part of me wonders why we only ever read articles about drugs that show "promise"? When was the last time we saw an article titled "Cure for Disease Found!"? And no, I don't have Alzheimers. I honestly can't recall.
The problem with this drug is that its promise is based on 2 assumptions:
1) that amyloid has a causal role in Alzheimers
2) lowering amyloid will halt or reverse Alzheimers
Given that we don't actually know that either is true, we really have no idea how good the promise of this drug is. What we DO know is that promises have made a lot of pharmaceutical companies and their management very very very rich. Not that I would begrudge them that if they actually come through with a halfway effective drug. But I also think there should be penalties for putting out media announcements and raising false hopes without even having tested it out on a single human being yet.
"The only normal people are the ones you don't know very well."
I wonder (and perhaps someone with more education than I can speculate), if amyloid concetrations in the brain are reduced, will the patients be able to remember things that they have forgotten, or will they "just" be capable of remembering new information again?
The sad thing is that with proper building design, it's possible to make life much better for people with severe dementia. Many people react like your father-in-law because they don't understand why they're not allowed to leave. Another nursing home run by the same organisation I work for was built a few years ago with a specific dementia ward, and apparently it's much better for the residents. By most places where there have to be closed doors, they've eliminated much of the points for someone to focus on. The ward is designed as a circle with a garden breaking the ring, and the only entrance/exit is from the garden. Most people with severe dementia will wander in circles, getting distracted by the garden or other points. If you google for it there's actually been a lot of research done over the last fifteen years into caring for people with dementia, but that takes a while to filter into actual nursing homes. We're knocking our facility down and rebuilding sometime in the next five years, hopefully with some better design principles for the people we're handling.
[clever sig]